Fortis Healthcare rejects over pricing of drugs charge
Fortis Healthcare has rejected charges of overpricing the medicines that it is giving to its patients.In a statement, it said, "Fortis Healthcare does not charge any drug or consumables above the printed MRP and there is No Violation of Drug Price Control Order. It should also be noted that our end price to the patient is very much in line with what other private hospitals in India charge."
Dec 16, 2017, 16:01 PM IST
Give exemption from drug price control for 5 years: Mazumdar-Shaw
Seeking a five-year exemption from drug price control, Biocon CMD Kiran Mazumdar-Shaw Wednesday asked the government to refrain from 'ad hoc' measures so as to enable the pharma sector to build scale to be globally competitive.
Apr 06, 2016, 17:53 PM IST
Medicines may become cheaper as panel recommends capping of profit, cutting drug prices
A report by an inter-ministerial committee has made recommendations that trade margins trade margins of costly drugs be capped at 35% of maximum retail price.
Mar 09, 2016, 11:37 AM IST
India 'privately' against patent-overriding drug permits
Indian government has "privately reassured" industry lobby group US-India Business Council that the country would not invoke 'compulsory licensing' for commercial purposes that could allow local drugmakers to make cheaper products by overriding patents of big global players.
Mar 09, 2016, 09:22 AM IST
NPPA warns drug cos over non-registration with online database
With just 41 out of top 100 pharma firms responding to its direction to register for online database, drug price regulator NPPA has warned to take action if the rest of the companies did not comply with its order immediately.
May 04, 2015, 21:59 PM IST
Govt allows pharma companies to hike prices of 509 essential drugs
The government has allowed pharmaceutical companies to hike rates of 509 essential medicines used for treating various ailments like diabetes, hepatitis and cancer by 3.84 percent with effect from April 1.
Apr 08, 2015, 14:35 PM IST
NPPA yet to recover Rs 3,680 cr for drug price overcharging
Drug price regulator NPPA is still to recover Rs 3,680.43 crore from various pharmaceutical companies for overcharging, while almost 95 per cent of the amount is under litigation.
Mar 15, 2015, 13:40 PM IST
Govt forms committee for revising List of Essential Medicines
The government formed core committee, comprising drug price regulator NPPA and Department of Pharmaceutical, for revision of National List of Essential Medicines is yet to submit its report.
Dec 19, 2014, 15:59 PM IST
DrReddy's, Sun Pharma among 14 firms probed by US over drug price
India's pharma majors Dr Reddy's and Sun Pharma are among 14 drug makers which are being probed by the US Congress over price escalation of generic drugs.
Oct 08, 2014, 21:06 PM IST
